.jpg)
Biofarma Group takes another step forward in its international growth strategy with the acquisition of a 70% stake in EuroPharma Alliance, a Polish company specialising in the contract development and manufacturing of food supplements.
Based in the Wrocław area, EuroPharma Alliance serves international pharmaceutical companies and Consumer Health brands across several European markets. Its manufacturing facility in Rzeplin features production lines for softgel capsules, tablets, hard capsules, powders and liquids, supported by in-house teams specialising in product development and regulatory affairs.
The company's entry into the Group builds on the expansion initiated with the acquisition of EmergoPharm, completed in September 2026. The two companies bring complementary expertise: on the one hand, product development and regulatory support; on the other, strong local manufacturing capabilities. Together, they contribute to the creation of an integrated hub in Poland, enabling Biofarma Group to support customers across Central and Eastern Europe throughout the entire process, from product development to the manufacturing of finished products.
This direct presence in a particularly dynamic region for the European nutraceutical market will allow the Group to work more closely with its customers, leverage the expertise of its different companies and create new opportunities for collaboration.
«The acquisition of EuroPharma Alliance further strengthens our presence in Central and Eastern Europe and naturally complements EmergoPharm. With a manufacturing platform in Poland, we can integrate product development with local production, offering customers across the region a comprehensive service, from concept to finished product» – Alberto Urli, CEO of Biofarma Group.
Founder Piotr Jandziak will retain a 30% stake in the company and continue to contribute to its development, working alongside the Group to implement a shared growth plan.
«Joining Biofarma Group opens a new chapter for EuroPharma Alliance. The Group's scale, scientific expertise and international customer network will allow us to accelerate our growth and expand our capabilities, while preserving the flexibility and customer focus that set us apart» – Piotr Jandziak, Founder and CEO of EuroPharma Alliance.
With EuroPharma Alliance, Biofarma Group further expands its industrial capabilities and strengthens the connections between its different companies. Another step towards building a global integrated platform that brings together expertise, people and manufacturing facilities, while keeping customer needs at its core.
